2021 8th Annual Kentucky - Viral Hepatitis Conference Call to ACTION: The Role of Professionals in Hepatitis Elimination
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Kentucky Rural Health Association
2021 8th Annual Kentucky
Viral Hepatitis Conference
Call to ACTION:
The Role of Professionals in Hepatitis Elimination
Conference Agenda
Virtual Conference
July 28, 2021
Kentucky’s 8th Annual Viral Hepatitis Conference
July 28, 2021
I
TIME PRESENTATION FACULTY
7:45 AM-8:00 AM Introduction & Roll Call for CEU's
8:00 AM-8:05 AM Welcome and Opening Remarks KaSandra Hensley, Northeast AEHC, President Elect
Kentucky Rural Health Association
8:05 AM- 9:05AM Call to Action: The Nations Viral Hepatitis Action Neil Gupta MD, MPH
Plan and Elimination of Viral Hepatitis in Chief of the Epidemiology & Surveillance Branch in Center for
Appalachia Disease Control Division of Viral Hepatitis.
9:05 AM-10:05 AM Kentucky Department for Public Health Call to Doug Thoroughman, PhD
Action: Viral Hepatitis Elimination in Kentucky KY Department for Public Health
and the Appalachian Region
10:05 AM-10:15 AM Morning Break Sponsor Breakout Gilead Sciences
10:15 AM- 11:15 AM Call for Action: The Impact of Covid 19 on Fadi Al Akhrass, MD
Hepatitis C Elimination
11:15 AM-12:00 PM Call for Action: Hepatitis C Infection and the Jon Zibbell, PhD
Opioid Epidemic in America
12:00 PM-1:00 PM Lunch AbbVie
Sponsor Outbreak
1:00 PM- 2:00 PM Kentucky Answers the Call to Action: William Balistreri, MD
Kentucky’s Model for Standard of Care for Claudia Espinosa, MD, MSc-
Children and Pregnant Women with HCV and
Their Infants
2:00 PM-3:00 PM Answering the Call to Action- Kentucky Barbra Cave, PhD APRN
Projects: A FOCUS on Hepatitis C Screening and Bennett Cecil, MD
Linkage to Care Projects in Kentucky. The Role Jens Rosenau, MD
of Expert Mentoring in the Elimination of
Hepatitis C in Appalachia:
ECHO, Telehealth & KHAMP Projects
3:00 PM-3:15 PM Afternoon Break
Sponsor Breakout
3:15 PM-4:00 PM Norton Healthcare Answering the Call to Action Michelle Rose, MBA
Through the Eyes of a Patient Navigator
4:00 PM- 4:30 PM ER Testing Answering the Call for Action: Daniel Moore, MD
Hepatitis C Testing in the ER Mobilizing
4:30 PM-5:00 PM Calling YOU to Action: Kathy Sanders, MSN RN
Questions, Answers & Closing Remarks Tina McCormick, BS
n,
2021 Viral Hepatitis Conference
Ending the Epidemic:
The Role of Professionals in Hepatitis Elimination
Course Description
The purpose of this conference is to provide the most up-to-date information on hepatitis
A, B and C epidemiology, diagnosis, management, treatment and prevention, which will
assist health service providers to offer the most effective care to persons infected with
hepatitis A, B or C. By promoting collaborations and the sharing of knowledge, ideas and
experience, we can continue to make advances and bridge the gap in the prevention and
management of hepatitis infections throughout the Appalachia Region.
Course Objectives
1. Discuss the impact of a national strategy and the U.S. Viral Hepatitis Action Plan on
creating an effective HCV service delivery system and national strategy for creating an
effective HCV service delivery system.
2. Discuss the impact of the increases of hepatitis infection related to the growing opioid
epidemic in Kentucky and the U.S. Describe injection drug use and describe ways to
enhance access to health care services for substance users.
3. Identify the procedures conducted during the pre-treatment evaluation of a patient with
HAV, HBV and HCV, best practices for screening, diagnosing, linkage to care. State the
burden of hepatitis A, hepatitis B and hepatitis C disease in Kentucky and the Appalachia
Region.
4. Discuss new screening strategies to identify persons infected with HBV and HCV. Describe
the infrastructure necessary to support hepatitis care and treatment in primary care
settings.
5. Discuss novel interventions used in other jurisdictions throughout the US to address an
HAV and HCV outbreaks.
6. Discuss procedures conducted for screening on HCV, perinatal transmission; screening,
testing, and treatment of infants born to mothers with HCV and HBV.
7. Discuss the latest clinical drug trails for HCV treatment in children.
8. Discuss recent changes to Kentucky’s Medicaid Program and how these changes impact
viral hepatitis treatment in Kentucky.
9. Discuss viral hepatitis and opportunities to mobilize community action.
William F. Balistreri, MD
Dorothy M.M. Kersten Professor of Pediatrics
University of Cincinnati College of Medicine
Director Emeritus, Pediatric Liver Care Center
Medical Director Emeritus, Liver Transplantation
Program Director Emeritus, Fellowship in Transplant Hepatology
Division of Pediatric Gastroenterology, Hepatology, & Nutrition
Cincinnati Children’s Hospital Medical Center
Through more than 550 publications, Dr. Balistreri has helped to clarify the understanding
of many aspects of liver diseases in children. His innovative research has addressed many
aspects of hepatobiliary diseases in children, including neonatal cholestasis, metabolic liver
disease, and viral hepatitis. Balistreri has been editor of The Journal of Pediatrics since
1995. He is the former editor-in-chief of the Journal of Pediatric Gastroenterology and
Nutrition, and co-editor, associate editor, guest editor, reviewer and member of numerous
editorial boards of several journals. He is co-editor of the prestigious text Liver Disease in
Children.
In 2000, Balistreri became the first pediatrician to serve as president of the American
Association for the Study of Liver Diseases. In addition, he has received numerous awards.
These include the Distinguished Leadership Award from the CCFA; the Andrew Sass-
Kortsak Memorial Award from the Canadian Liver Foundation and the Canadian
Association for the Study of Liver; The Distinguished Alumnus Award, University of Buffalo
and The Distinguished Alumnus Award, University of Cincinnati, College of Medicine; the
Distinguished Service Award from AASLD; and the Distinguished Educator Award from the
American Gastroenterological Association. He received the Outstanding Pediatrician award
from the Ohio Chapter of the American Academy of Pediatrics for distinguished
achievements in pediatric care and in the education of patients and physicians.
In 2012, NASPGHAN established the William F. Balistreri, MD, Prize for Excellence in
Pediatric Gastroenterology, Hepatology and Nutrition. This award will recognize
outstanding achievement in an area relevant to the field to be bestowed each year at the
annual NASPGHAN meeting. Balistreri joined Cincinnati Children's in 1978. He served as
division director of Pediatric Gastroenterology, Hepatology, and Nutrition for 25 years.
Balistreri has been listed multiple times in Best Doctors in America.
Barbra Cave, PhD, APRN, FNP-BC
Assistant Professor
University of Louisville School of Medicine Christina Lee Brown
Environmental Institute Division of Environmental Health
Hep C Program Lead
University of Louisville Hospital Hep C Center
Barbra Cave, PhD, APRN is a board-certified family nurse practitioner and assistant professor in the
Christina Lee Brown Envirome Institute at the University of Louisville School of Medicine. She
serves as the Hep C Program Lead for the UofL Hospital Hep C Center. She is the principal
investigator on multiple industry-sponsored grants and is working toward gaining NIH funding.
Much of her work focuses on people living with viral hepatitis infections and improving access to
care and treatment, with special attention to pregnant women and people who use drugs.
Dr. Cave earned two undergraduate and her masters degrees at Bellarmine University in Louisville.
She worked nearly five years in the Transplant ICU at Jewish Hospital and was a certified critical
care registered nurse before becoming a nurse practitioner in 2010. In 2019, she graduated from
the University of Louisville with her PhD in Nursing. She received training specific to her roles in
gastroenterology and hepatology through her work with medical faculty at the University of
Louisville Division of Gastroenterology, Hepatology, and Nutrition.
Dr. Cave has co-authored several publications and delivered numerous podium presentations at
local, state, and national conferences. She serves as a faculty presenter for the Chronic Liver
Disease Foundation (CLDF), Kentucky Hepatitis Academic Mentorship Program (KHAMP),
Gastroenterology/Hepatology Advanced Practice Providers (GHAPP), and the Scripps Clinic Liver
Research Consortium. She is a member of the American Association for the Study of Liver Disease
(AASLD) and serves on the Hepatology Associates Committee. As of January 2021, Dr. Cave is chair
of the inaugural Research Committee for GHAPP. She is a member of the American Association of
Nurse Practitioners, and the Kentucky Coalition of Nurse Practitioners and Nurse Midwives. She is a
board member for the Kentucky Harm Reduction Coalition.
Bennett Cecil, MD
Medical Director of Hepatitis C Treatment Centers
Dr. Cecil is a gastroenterologist in Louisville focused on HCV care and treatment since 1998. He is the
medical director of Hepatitis C Treatment Centers, located in Louisville and Russell Springs and
throughout Central and Eastern Kentucky.
Dr. Claudia Espinosa, MD
Associate Professor University of South Florida
Dr. Claudia Espinosa attended medical school at the Universidad del Cauca Facultad de
Ciencias de la Salud in Colombia, completed a residency in pediatrics at the University of
Kansas School of Medicine, and a fellowship in pediatric infectious diseases at the
University of Michigan. She also has a Master in Science in Health Services Research from
the University of Michigan. Dr. Espinosa was at the University Of Louisville School Of
Medicine until 2019. Dr. Espinosa joined the University of South Florida in August 2019 as
an Associate Professor.
Dr. Espinosa’s research interests focus on neonatal and perinatal infectious diseases,
including hepatitis B, C and HIV. She worked along with other institutions to promote
universal testing of hepatitis C among pregnant women in Kentucky. Dr. Espinosa has
participated in multiple clinical trials for antimicrobials and vaccines, and she also has
developed and implemented successful protocols for the management of infants with
perinatal exposure to a range of pathogens.
Neil Gupta, MD, MPH
Chief of the Epidemiology & Surveillance Branch in
CDC’s Division of Viral Hepatitis
Neil Gupta, MD, MPH is board certified in Internal Medicine and Preventive Medicine and
joined the Centers of Disease Control and Prevention in 2010 as an Epidemic Intelligence
Service Officer. From 2014-2018, he served as country implementation team lead for
CDC’s International Infection Control Program, where he supported national efforts to
strengthen infection control programs and implement surveillance for healthcare-
associated antimicrobial-resistant pathogens in several countries in Asia, Africa, and
South America. In this role, Dr. Gupta served as CDC’s team lead for infection prevention
and control during the Ebola outbreak in Liberia, and played a leading role in > 10
outbreaks investigated by CDC.
Since December 2018, Dr. Gupta has been serving as the Incident Manager of CDC’s
national hepatitis A outbreak response, overseeing CDC’s response efforts in
epidemiology, vaccine, laboratory testing, health policy, communications, and direct
assistance to states. In June 2019, Dr. Gupta became the new permanent Chief of the
Epidemiology & Surveillance Branch in CDC’s Division of Viral Hepatitis.
Fadi Al Akhrass, MD, MBA, FACP
Medical director of Infectious Control and Infectious Diseases at Pikeville
Medical Center Clinical
Adjunct professor of Internal Medicine, Infectious Diseases University of
Pikeville
Faculty at the Kentucky College of Osteopathic Medicine-University of
Pikeville and the Family Practice Residency Program
Dr Al Akhrass is the medical director of infectious diseases and infection prevention at Pikeville medial
center. Dr. Al Akhrass is Board-certified in internal medicine, with subspecialty certification in
infectious diseases. He is a fellow of the American College of Physicians and a member of the American
Medical Association and Kentucky Medical Association. Dr Al Akhrass’ research interests focus on
various types of infectious diseases, including COVID-19 vaccines, COVID-19 therapeutics, CDiff
infection, HCV, microbial infections, and, to that end, he has played an investigatory role on clinical
trials of agents to treat these infectious diseases.
Dr Al Akhrass was the media face of Pikeville Medical Center during the COVID-19 pandemic to educate
the public about mitigation measures and the importance of vaccination to curtail this raging virus.
Dr Al Akhrass is a Kentucky Colonel bestowed by Governor Beshear for his outstanding service during
covid-19 to the community of Eastern KY, the Stare of KY and the nation. Furthermore, he received a
citation honor by the Kentucky Senate for working on mitigation measures and increasing awareness
to the public during the covid-19 pandemic. Dr Al Akhrass was elected the citizen of the year by the
southeast Kentucky chamber of commerce in 2020
J.Daniel Moore, MD
Associate Professor Emergency Medicine
University of Kentucky
Dr. Daniel Moore is Associate Professor of Emergency Medicine
He graduated from the University of Kentucky, College of Medicine, Lexington. He completed
his Residency at the University of Alabama at Birmingham, Ala.
Dr. Moore is has received Certifications and Special :
American Board of Emergency Medicine
He is the project lead for the Gilead Focus Projection which offers hepatitis C screening for
patients in UK emergency departmentMichelle Rose, MBA
Manager of Population Health/ Infectious Disease
Norton Healthcare
Michelle Rose comes to Norton Healthcare following a more than 25 year career at senior
levels in population health and humanitarian response. Ms. Rose has a Bachelor’s of Art in
Geography from Humboldt State University in Arcata, California and a Master’s of
Business Administration from HEC (École des hautes études commerciales de Paris) Paris,
in Jouy-en-Josas, France. Ms. Rose is a long-time patient advocate within the areas of
sexual and reproductive health, with strong investigation emphasis in the areas of HIV and
viral hepatitis.
Presently, she serves as the Manager of Population Health within Infectious Disease at
Norton Healthcare in Louisville, Kentucky. In this role, Ms. Rose analyzes large disease-
state data sets, care delivery systems, and broader health and social systems to develop
population-based care models that integrate EMR optimization, clinical flow, payors,
legislation and policy. The policy and legislative work Ms. Rose is best known for within
the US includes her pioneering work in universal screening of hepatitis C in pregnant
women and modernizing HIV screening. During the 2018 and 2019 Kentucky Legislature
Regular Sessions, Ms. Rose worked directly with policy makers to help draft Senate Bill
250, universal HCV in pregnant women and House Bill 439, which eliminated significant
barriers to HIV screening and linkage to care. Both Bills became laws and passed with
strong bipartisan support. Prior to relocating to Louisville, Kentucky Ms. Rose called Sub-
Saharan Africa her home where she lived and worked in 20 of the 54 countries in the
region. While in Africa, Ms. Rose managed international development and emergency
response projects that directly aided populations marginalized by infectious diseases and/
or displaced through conflicts, wars or/and natural disasters. Ms. Rose’s last international
assignment was in Sierra Leone where she spent 18 months managing 625 international
clinicians at two Ebola treatment center and rebuilding healthcare care systems.Jens Rosenau, MD
Associate Professor of Medicine, University of Kentucky
Hepatologist and Gastroenterologist
Division of Digestive Diseases & Nutrition
Kentucky Clinic
J
Jens Rosenau, MD, is a hepatologist and general gastroenterologist in the Division of
Digestive Diseases and Nutrition at the University of Kentucky in Lexington. Dr. Rosenau is
board certified in Internal Medicine and Gastroenterology.
Dr. Rosenau’s special interests include viral Hepatitis and liver transplantation. He has
published over 60 original articles, review articles and abstracts, and he has conducted
multiple clinical trials. He has received awards for some of his research projects and he has
provided peer reviews for multiple scientific journals.
Dr. Rosenau is a member of the American Association for the Study of Liver Disease
(AASLD) and the European Association for the Study of the Liver (EASL).
Dr. Rosenau received his medical degree from Hannover Medical School in Hannover
Germany. He completed his residency in Internal Medicine as well as his fellowship in
Gastroenterology at Hannover Medical School. He currently holds a faculty position at the
University of Kentucky as an Associate Professor of Medicine and he is the Medical Director
of the Liver Transplant Program of the University of Kentucky.CAPT Doug Thoroughman, PhD
U.S. Centers for Disease Control and Prevention (CDC) Career
Epidemiology Field Officer
CAPT Doug Thoroughman, a career officer of the U.S. Public Health Service, is a U.S.
Centers for Disease Control and Prevention (CDC) Career Epidemiology Field Officer
who has been assigned to the Kentucky Department for Public Health (KDPH) since
August, 2002. He began his public health career during a U.S. Peace Corps assignment to
Liberia, West Africa, where he worked on a childhood immunization project. He earned
a PhD in Epidemiology at Emory University in 1996 and joined CDC’s Epidemic
Intelligence Service (EIS) immediately after graduation. He was assigned to the Indian
Health Service (IHS) Headquarters Epidemiology Program in Albuquerque, New Mexico
from 1996 to1998. He subsequently served IHS as their National Hepatitis Coordinator
from 1999-2002, when he came to Kentucky to help build public health preparedness
and epidemiologic capacity. He has served as the Deputy State Epidemiologist for
Kentucky since 2013 and as the Acting State Epidemiologist in 2016-17 and from April
2018 to May 2019. He is currently the Scientific Response Manager for the COVID-19
Incident Command Structure at KDPH where he is coordinating and overseeing the
epidemiologic component of the COVID-19 response in Kenrtucky.Jon E. Zibbell, PhD
Senior Public Health Scientist
RTI International
Jon E. Zibbell, PhD. conducts behavioral and community-based epidemiological research on
risk factors and health outcomes associated with the opioid epidemic and injection drug
use. He is a Medical Anthropologist with two decades of field experience in the areas of
injection drug use, opioid use disorder, and injection-related infectious disease.
Previously, Dr. Zibbell worked as a CDC Health Scientist in the Division of Viral Hepatitis
and Unintentional Injury Prevention, conducting epidemiological and surveillance research
on viral injuries and infections caused by drug use behaviors. In addition to research, he
has conducted rapid ethnographic needs assessments for community-based syringe service
and overdose prevention programs and continues to assist states and community
organizations to develop evidence-based approaches to reduce morbidity and mortality
associated with opioid epidemic.
Dr. Zibbell’s work has appeared in both academic and professional journals and he holds a
joint adjunct appointment in the Center for the Study of Human Health and the Department
of Anthropology at Emory University. Dr. Zibbell received a Bachelor of Science in Natural
Resource Studies; a Master’s of Art in Anthropology and a PhD. in Anthropology (Medical)
from the University of Massachusetts/Amherst.2021 Viral Hepatitis Conference
Ending the Epidemic:
The Role of Professionals in Hepatitis
Elimination
Tina McCormick, BS Conference
Planning Committee
Susan Moser, BSN RN
Conference Planning Committee
Kathy J. Sanders, MSN RN
Conference Planning CommitteeYou can also read
